The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $676,094 in first-year total cost, median $237,750.
Most frequent study sections
- Special Emphasis Panel[ZRG1 AARR-Q (51)]3
Most frequent institutions
- CINCINNATI CHILDRENS HOSP MED CTR1
- TEMPLE UNIV OF THE COMMONWEALTH1
- UNIVERSITY OF CALIFORNIA, SAN FRANCISCO1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2018 | HIV-1 Particle Capture and VCC Formation in Microglia1R21NS107031-01 | SPEARMAN, PAUL W. | CINCINNATI CHILDRENS HOSP MED CTR, OH | $238,500 | ZRG1 |
| 2018 | CRISPR-mediated inactivation of ALCAM in myeloid cells1R21MH116690-01 | KAMINSKI, RAFAL | TEMPLE UNIV OF THE COMMONWEALTH, PA | $237,750 | ZRG1 |
| 2018 | Biomarkers of CNS HIV Persistence1R21MH116716-01 | HENRICH, TIMOTHY JENSEN | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $199,844 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.